AACR-Novocure Career Development Award for Cancer Research supports early-career investigators studying Tumor Treating Fields to clarify their mechanisms and advance cancer treatment strategies.
Funder: American Association for Cancer Research
Due Dates (Anticipated): June 2027 (Application deadline)
Funding Amounts: $300,000 USD over three years
Summary: Supports early-career investigators studying Tumor Treating Fields to clarify their mechanisms and advance cancer treatment strategies.
Key Information: Experimental designs must include the Inovitro® system, and funding requires an institutional Materials Transfer Agreement with Novocure.
This joint initiative of the American Association for Cancer Research (AACR) and Novocure supports early-career investigators conducting innovative research on Tumor Treating Fields (TTFields). These intermediate-frequency, low-intensity alternating electric fields disrupt cancer cell division. The award aims to deepen understanding of TTFields mechanisms, encourage investigators to enter the field, and accelerate new cancer treatment strategies.
Basic and translational research is supported. Priority goes to studies moving in vitro findings into in vivo systems, combination therapies involving TTFields, and translational projects bringing TTFields treatments toward the clinic. Inter-laboratory collaboration is encouraged, particularly for investigators new to TTFields research.